Compare Baxter International Inc (BAX) vs Manchester United PLC (MANU) Price & Performance

Baxter International Inc. (BAX) trades at $27.78, up 0.83% today, with a bullish technical outlook supported by moving averages. Recent Q2 2026 earnings beat estimates with EPS of $0.56 versus $0.37 expected, and revenue guidance was raised, signaling operational improvement. However, the company posted a net loss of -$957 million in 2025, with negative profit margins and high P/E of 87.85, reflecting valuation concerns amid turnaround efforts.

The stock shows potential from earnings momentum and cost initiatives, but high debt and inconsistent profitability pose risks. Analyst consensus is mixed with a $25.43 price target below current levels, suggesting cautious optimism. Investors should weigh recent beats against structural challenges in the medtech sector.

Manchester United (MANU) trades at $21.70, up 0.32% on the day, with a bearish technical signal but improving fundamentals. Recent Q1 2026 earnings beat expectations, though the company remains unprofitable with a net income margin of -2.65%. Key developments include securing land for a new 100,000-seat stadium and Champions League qualification, which may boost future revenue.

The outlook is mixed: operational improvements and stadium plans offer long-term growth potential, but persistent losses, high debt, and weak cash conversion pose risks. Analyst sentiment is cautious with 40% buy ratings. Investors should weigh recovery prospects against financial stability concerns.